The 8x5 Diet for Bile Acid Diarrhoea: A Feasibility Randomised Controlled Trial
1 other identifier
interventional
76
1 country
1
Brief Summary
Bile acid diarrhoea is a common cause of chronic watery diarrhoea. Treatment is life-long medication. However, about 50% of people have ongoing, bothersome diarrhoea. Findings from recent research on diet therapies and food intolerances have been used to develop a healthy dietary pattern called The 8x5 Diet. We will test the practicalities of conducting a randomised controlled trial of this dietary intervention.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Apr 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 6, 2024
CompletedFirst Posted
Study publicly available on registry
February 14, 2024
CompletedStudy Start
First participant enrolled
April 2, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 31, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
March 31, 2025
CompletedDecember 16, 2024
December 1, 2024
12 months
February 6, 2024
December 10, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (6)
Consent
The number (%) of participants who consent to participate in the trial compared to the number (%) that were screened by the research team.
Recruitment period (50 weeks)
Recruitment
The number (%) of participants randomised compared to the number (%) that were eligible (screened by the research team)
Recruitment period (50 weeks)
Randomisation
The number (%) of participants who complete their first appointment compared to the number (%) that were randomised, intervention group only.
Recruitment period (50 weeks)
Retention
Tthe number (%) of participants that completed the study compared to the number (%) randomised to each group.
Randomisation to trial completion (8 weeks)
The trial's data collection instruments and procedures: Missing data
The number and proportion of missing data identified by the research team from questionnaires.
At baseline and at Week 8
The trial's data collection instruments and procedures: Participants' views and experiences
Participants' views and experiences of the instruments (questionnaires and diaries) and procedures (screening, randomisation, baseline period, trial, general)
Study identification to study completion (Week 8)
Study Arms (2)
The 8x5 Diet
ACTIVE COMPARATORThe 8x5 Diet is a healthy dietary pattern administered virtually by a specialist dietitian
Control
NO INTERVENTIONContinuation of habitual diet, no dietary changes.
Interventions
A virtual, dietitian-counselled, healthy dietary pattern defined by its fat intake, its daily eating pattern, keeping adequately hydrated, having a variety of whole grains, fruit and vegetables, and use of certain plant fibres.
Eligibility Criteria
You may qualify if:
- Age ≥ 18 years, of any ethnic group, living in the United Kingdom and not planning to move home for the next three months
- Self-reported diagnosis of bile acid diarrhoea that was confirmed by 7-day SeHCAT testing
- Self-reported ongoing chronic diarrhoea despite use of appropriate medication
- Able to participate in either diet group with the intention to remain in the group to which they were assigned for the 8 week study period
- Body mass index ≥20 kg m-2
- Able to converse in English (or via their carer, without assistance from an interpreter) using a computer/laptop, smart phone, or tablet
- Able to provide informed written consent
- Able to provide the address of their general practioner so that the research team can inform them of their participation.
You may not qualify if:
- Unable to provide self-reported written confirmation that their diagnosis of bile acid diarrhoea was by SeHCAT testing
- Pregnant/breastfeeding/planning a pregnancy in the next six months
- Inflammatory bowel disease, previous or current microscopic colitis, or other serious morbidities such as liver disease, pancreatic disease, AIDS/HIV, radiotherapy for cancer, assessed at screening via patient self-report
- Diarrhoea that is inadequately active: \<3 stools per day or \<1 watery stool (Bristol Stool Form types 6-7) per day as the mean of one week
- Currently participating in another research study or has taken part in the previous 3 months
- If taking insulin, metformin (other than slow-release), anti-obesity medication, or using commercially available formulated supplements to replace meals in previous three months
- Use of antibiotics in the previous four weeks
- Food allergies, other than oral allergy syndrome/pollen-food syndrome
- An eating disorder or disordered eating which is active or in the last 12 months
- Alcohol or drug abuse, or self-harm, or depression, or suicide ideation in the last 12 months
- Shift worker
- If unwilling to keep a weighed 7-day food diary
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Yvonne McKenzie
Manchester, Greater Manchester, M13 9PL, United Kingdom
Related Publications (1)
McKenzie YA, Kelman L, O'Connor M, Todd C, Walters JR, Burden S. Diet therapy (The 8x5 Diet) for adults living with bile acid diarrhoea: protocol for a feasibility randomised controlled trial. BMJ Open. 2025 Mar 27;15(3):e097973. doi: 10.1136/bmjopen-2024-097973.
PMID: 40147991DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Christopher Todd, Professor
The University of Manchester
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- PhD Candidate
Study Record Dates
First Submitted
February 6, 2024
First Posted
February 14, 2024
Study Start
April 2, 2024
Primary Completion
March 31, 2025
Study Completion
March 31, 2025
Last Updated
December 16, 2024
Record last verified: 2024-12